Compare FMNB & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FMNB | VOR |
|---|---|---|
| Founded | 1887 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.3M | 562.6M |
| IPO Year | 2010 | 2021 |
| Metric | FMNB | VOR |
|---|---|---|
| Price | $12.93 | $15.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 10 |
| Target Price | $14.33 | ★ $64.78 |
| AVG Volume (30 Days) | 478.5K | ★ 703.9K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.06% | N/A |
| EPS Growth | N/A | ★ 2.86 |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $269,448,000.00 | N/A |
| Revenue This Year | $52.63 | N/A |
| Revenue Next Year | $8.28 | N/A |
| P/E Ratio | $12.69 | ★ N/A |
| Revenue Growth | ★ 5.58 | N/A |
| 52 Week Low | $11.58 | $0.13 |
| 52 Week High | $15.50 | $49.95 |
| Indicator | FMNB | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 41.13 | 57.69 |
| Support Level | $12.88 | $11.27 |
| Resistance Level | $13.70 | $16.80 |
| Average True Range (ATR) | 0.32 | 1.19 |
| MACD | -0.02 | 0.29 |
| Stochastic Oscillator | 21.32 | 62.55 |
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.